Strategic Growth Opportunities in the Gene Therapy for Age-Related Macular Degeneration Market
The ophthalmic gene therapy industry is experiencing significant transformation as innovative genetic treatments offer new hope for patients with age-related macular degeneration. The Gene Therapy for Age-Related Macular Degeneration Market is valued at USD 1 billion in 2025 and projected to reach USD 5 billion by 2035 at a CAGR of 13.1%. This article explores strategic growth...
0 التعليقات 0 المشاركات 7 مشاهدة 0 معاينة